Heart Failure Hospitalizations Linked to Iron Deficiency in CKD
Early detection of iron status may improve cardiovascular risk assessment in patients with CKD, according to investigators.
Diagnosis & Disease Information
RBC Transfusion Rates No Worse With Low Fixed-Dose Darbepoetin
Investigators sought to define an ESA dosing regimen that reduces the likelihood of transfusion while minimizing any potential cardiovascular risks.
Vadadustat NDA Submitted for Anemia Due to Chronic Kidney Disease
Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
COVID-19 Antibodies Found in 1 in 5 US Blood Donations
Percentage of donations with antibodies has risen steadily over time, according to the Red Cross
Investigators ID Factors Affecting Predialysis Hemoglobin Control
Study findings reinforce the value of treating anemia during the transition to dialysis and illustrate the problem of ESA hyporesponsiveness.
World Kidney Day 2021: Living Well With Kidney Disease
The World Kidney Day Steering Committee has declared 2021 the year of “Living Well with Kidney Disease”.
Canagliflozin May Reduce Anemia Risk in Diabetic CKD
In the CREDENCE trial, patients receiving canagliflozin had reduced risks of initiating iron therapy and erythropoiesis-stimulating agents compared with patients receiving placebo.
Iron Replacement Therapy Triferic AVNU Now Available
Triferic is an iron maintenance therapy that delivers between 5 to 7mg of iron with every hemodialysis treatment and maintains hemoglobin without increasing ferritin.
Early Transfusion May Not Worsen Kidney Graft Outcomes in Selected Cases
Perioperative transfusion of blood products was not associated with worse clinical outcomes or allosensitization in a study of selected kidney transplant recipients.
FDA Requests Clarification of Data to Complete Roxadustat Review
The Agency announced that additional clarification of clinical data was needed prior to completing the review.
- Loading...
Loading...
Next post in Anemia
Loading... 
Loading...